In order to deliver Dox to MUC1-positive tumor cells, an aptamer-doxorubicin complex (Apt-Dox) was formed by intercalating doxorubicin into the DNA structure of the MA3 aptamer. The gene discussed is PNMA3; the disease is neoplasm.